Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CD44 expression in benign and malignant colorectal polyps.

R Neumayer1, H R Rosen, A Reiner

  • 1Department of Pathology, Ludwig Boltzmann Research Institute for Surgical Oncology, Vienna, Austria.

Diseases of the Colon and Rectum
|April 22, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rescue of BDNF expression by the thalamic parafascicular nucleus with chronic treatment with the mGluR2/3 agonist LY379268 may contribute to the LY379268 rescue of enkephalinergic striatal projection neurons in R6/2 Huntington's disease mice.

Neuroscience letters·2021
Same author

Embryoscopy and karyotype findings of repeated miscarriages in recurrent pregnancy loss and spontaneous pregnancy loss.

Journal of assisted reproduction and genetics·2018
Same author

Prospective associations of C-reactive protein (CRP) levels and CRP genetic risk scores with risk of total knee and hip replacement for osteoarthritis in a diverse cohort.

Osteoarthritis and cartilage·2018
Same author

Effect of early embryonic deletion of huntingtin from pyramidal neurons on the development and long-term survival of neurons in cerebral cortex and striatum.

Neurobiology of disease·2017
Same author

Quality assurance trials for Ki67 assessment in pathology.

Virchows Archiv : an international journal of pathology·2017
Same author

Type-specific photoreceptor loss in pigeons after disruption of parasympathetic control of choroidal blood flow by the medial subdivision of the nucleus of Edinger-Westphal.

Visual neuroscience·2016

CD44 standard protein and CD44v6 expression levels vary between benign and malignant colorectal polyps. These CD44 variants may serve as biomarkers for polyp aggressiveness, warranting further clinical investigation.

Area of Science:

  • Oncology
  • Gastroenterology
  • Molecular Pathology

Background:

  • Colorectal polyps range from benign adenomas to early invasive cancers.
  • Identifying markers for aggressive biologic potential in polyps is crucial for patient management.
  • CD44 proteins, including standard and variant isoforms, are implicated in cell adhesion and cancer progression.

Purpose of the Study:

  • To investigate the expression of CD44 standard protein and CD44v5/v6 isoforms in colorectal adenomas and early invasive cancers.
  • To determine if CD44 expression patterns can characterize colorectal polyps with a more aggressive biologic potential.

Main Methods:

  • Retrospective analysis of 81 colorectal polyps (57 adenomas, 24 carcinomas-in-adenomas).
  • Immunohistochemical staining using specific monoclonal antibodies for CD44 standard, CD44v5, and CD44v6.

Related Experiment Videos

  • Statistical analysis to correlate CD44 expression with polyp grade and invasiveness.

    • Main Results:

    • CD44 standard protein was expressed in 63% of polyps, CD44v5 in 59%, and CD44v6 in 27%.
    • CD44 standard protein expression decreased with increasing adenoma grade and invasiveness (P < 0.0001).
    • CD44v6 expression was significantly higher in early invasive cancers (54%) compared to adenomas (7-25%, P = 0.00003).

    Conclusions:

    • CD44 standard protein and CD44v6 expression patterns differ significantly between benign and malignant colorectal polyps.
    • These CD44 variants show potential as biomarkers for characterizing the biologic potential of colorectal polyps.
    • Larger clinical studies are needed to confirm the prognostic value of CD44 in colorectal polyps.